Mesut Bilgin

Dr. Mesut Bilgin


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2020 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
INInger Ødum Nielsen
Inger Ødum Nielsen
AOAndré Vidas Olsen
André Vidas Olsen
JDJano Dicroce-Giacobini
Jano Dicroce-Giacobini
EPElena Papaleo
Elena Papaleo
KAKlaus Kaae Andersen
Klaus Kaae Andersen
MBMesut Bilgin
Mesut Bilgin

13 August 2019 in Diabetologia
Verified
Journal Article
Open access
PDF file
LHLaurits J. Holm
Laurits J. Holm
MHMartin Haupt-Jorgensen
Martin Haupt-Jorgensen
JGJano D. Giacobini
Jano D. Giacobini
JHJane P. Hasselby
Jane P. Hasselby
MBMesut Bilgin
Mesut Bilgin
KBKarsten Buschard
Karsten Buschard
Aims/hypothesis Sphingolipid metabolism regulates beta cell biology and inflammation and is abnormal at the onset of type 1 diabetes. Fenofibrate, a regulator of sphingolipid metabolism, is known to prevent diabetes in NOD mice. Here, we aimed to investigate the effects of fenofibrate on the pancreatic lipidome, pancreas morphology, pancreatic sympathetic nerves and blood glucose homeostasis in NOD mice. Methods We treated female NOD mice with fenofibrate from 3 weeks of age. The pancreatic lipidome was analysed using MS. Analysis of pancreas and islet volume was performed by stereology. Islet sympathetic nerve fibre volume was evaluated using tyrosine hydroxylase staining. The effect on blood glucose homeostasis was assessed by measuring non-fasting blood glucose from age 12 to 30 weeks. Furthermore, we measured glucose tolerance, fasting insulin and glucagon levels, and insulin tolerance. Results We found that fenofibrate selectively increases the amount of very-long-chain sphingolipids in the pancreas of NOD mice. In addition, we found that fenofibrate causes a remodelling of the pancreatic lipidome with an increased amount of lysoglycerophospholipids. Fenofibrate did not affect islet or pancreas volume, but led to a higher volume of islet sympathetic nerve fibres and tyrosine hydroxylase-positive cells. Fenofibrate-treated NOD mice had a more stable blood glucose, which was associated with reduced non-fasting and increased fasting blood glucose. Furthermore, fenofibrate improved glucose tolerance, reduced fasting glucagon levels and prevented fasting hyperinsulinaemia. Conclusions/interpretation These data indicate that fenofibrate alters the pancreatic lipidome to a more anti-inflammatory and anti-apoptotic state. The beneficial effects on islet sympathetic nerve fibres and blood glucose homeostasis indicate that fenofibrate could be used as a therapeutic approach to improve blood glucose homeostasis and prevent diabetes-associated pathologies.

26 August 2020 in Metabolomics
Verified
Journal Article
Closed access
PDF file
INInger Ødum Nielsen
Inger Ødum Nielsen
LGLine Groth-Pedersen
Line Groth-Pedersen
JDJano Dicroce-Giacobini
Jano Dicroce-Giacobini
AJAnna Sofie Holm Jonassen
Anna Sofie Holm Jonassen
MMMonika Mortensen
Monika Mortensen
KMKenji Maeda
Kenji Maeda

7 July 2023 in Oncogene
Verified
Journal Article
Open access
PDF file
ASAIKATERINI SKORDA
AIKATERINI SKORDA
ALAnna Røssberg Lauridsen
Anna Røssberg Lauridsen
CWChengnan Wu
Chengnan Wu
JHJinrong Huang
Jinrong Huang
MMMonika Mrackova
Monika Mrackova
Tuula KallunkiTuula Kallunki
Tuula Kallunki
Cancer cells are dependent on cholesterol, and they possess strictly controlled cholesterol homeostasis mechanisms. These allow them to smoothly switch between cholesterol synthesis and uptake to fulfill their needs and to adapt environmental changes. Here we describe a mechanism of how cancer cells employ oncogenic growth factor signaling to promote uptake and utilization of extracellular cholesterol via Myeloid Zinc Finger 1 (MZF1)-mediated Niemann Pick C1 (NPC1) expression and upregulated macropinocytosis. Expression of p95ErbB2, highly oncogenic, standard-treatment resistant form of ErbB2 mobilizes lysosomes and activates EGFR, invasion and macropinocytosis. This is connected to a metabolic shift from cholesterol synthesis to uptake due to macropinocytosis-enabled flow of extracellular cholesterol. NPC1 increase facilitates extracellular cholesterol uptake and is necessary for the invasion of ErbB2 expressing breast cancer spheroids and ovarian cancer organoids, indicating a regulatory role for NPC1 in the process. The ability to obtain cholesterol as a byproduct of increased macropinocytosis allows cancer cells to direct the resources needed for the energy-consuming cholesterol synthesis towards other activities such as invasion. These results demonstrate that macropinocytosis is not only an alternative energy source for cancer cells but also an efficient way to provide building material, such as cholesterol, for its macromolecules and membranes.

30 April 2017
Verified
Book Chapter
Closed access
PDF file
MBMesut Bilgin
Mesut Bilgin
JNJesper Nylandsted
Jesper Nylandsted
Marja JäätteläMarja Jäättelä
Marja Jäättelä
KMKenji Maeda
Kenji Maeda

5 June 2024 in Food Research International
Verified
Journal Article
Open access
RSRichard Remko Sprenger
Richard Remko Sprenger
MBMesut Bilgin
Mesut Bilgin
MOMarie S. Ostenfeld
Marie S. Ostenfeld
ABAnn Bjørnshave
Ann Bjørnshave
JRJan T. Rasmussen
Jan T. Rasmussen
CEChrister S. Ejsing
Christer S. Ejsing
Lipids from cow milk fat globule membranes (MFGMs) and extracellular vesicles (EVs) are considered beneficial for neurodevelopment, cognitive maintenance and human health in general. Nevertheless, it is largely unknown whether intake of infant formulas and medical nutrition products rich in these particles promote accretion of specific lipids and whether this affects metabolic homeostasis. To address this, we carried out a 16-week dietary intervention study where mice were supplemented with a MFGM/EV-rich concentrate, a control diet supplemented with a whey protein concentrate and devoid of milk lipids, or regular chow. Assessment of commonly used markers of metabolic health, including body weight, glucose intolerance and liver microanatomy, demonstrated no differences across the dietary regimes. In contrast, in-depth lipidomic analysis revealed accretion of milk-derived very long odd-chain sphingomyelins and ceramides in blood plasma and multiple tissues of mice fed the MFGM/EV diet. Furthermore, lipidomic flux analysis uncovered that mice fed the MFGM/EV diet have increased lipid metabolic turnover at the whole-body level. These findings help fill a long-lasting knowledge gap between the intake of MFGM/EV-containing foods and the health-promoting effects of their lipid constituents. In addition, the findings suggest that dietary sphingomyelins or ceramide-breakdown products with very long-chains can be used as structural components of cellular membranes, lipoprotein particles and signaling molecules that modulate metabolic homeostasis and health.